A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors

Although the majority of papillary thyroid cancer (PTC) is indolent, a subset of PTC behaves aggressively despite the best available treatment. A major clinical challenge is to reliably distinguish early on between those patients who need aggressive treatment from those who do not. Using a large coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Qing, Li, Xuechan, Acharya, Chaitanya R, Hyslop, Terry, Sosa, Julie Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369994/
https://www.ncbi.nlm.nih.gov/pubmed/28187428
http://dx.doi.org/10.18632/oncotarget.15128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369994/
https://www.ncbi.nlm.nih.gov/pubmed/28187428
http://dx.doi.org/10.18632/oncotarget.15128

Ejemplares similares